ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

FASEB: Focus on Research Funding, Not PR

June 14, 2013

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

Kimmel Donates $150 Million To Hopkins For Cancer Research, Patient Residence.

November 16, 2001

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013